NEUROCRINE BIOSCIENCES INC Earnings Per Share, Basic and Diluted
NEUROCRINE BIOSCIENCES INC (NBIX) reported Earnings Per Share, Basic and Diluted of -$1.12 per share for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-04-29.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2019-04-29
- NEUROCRINE BIOSCIENCES INC earnings per share, basic and diluted for the quarter ending 2019-03-31 was -$1.12.
- NEUROCRINE BIOSCIENCES INC earnings per share, basic and diluted for the quarter ending 2018-06-30 was -$0.07.
- NEUROCRINE BIOSCIENCES INC earnings per share, basic and diluted for the quarter ending 2018-03-31 was -$0.47.
- NEUROCRINE BIOSCIENCES INC earnings per share, basic and diluted for the quarter ending 2017-09-30 was -$0.13.
- NEUROCRINE BIOSCIENCES INC earnings per share, basic and diluted for fiscal 2016 was -$1.63.
- NEUROCRINE BIOSCIENCES INC earnings per share, basic and diluted for fiscal 2015 was -$1.05.
- NEUROCRINE BIOSCIENCES INC earnings per share, basic and diluted for fiscal 2014 was -$0.81.
- NEUROCRINE BIOSCIENCES INC earnings per share, basic and diluted for fiscal 2013 was -$0.69.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2019-03-31 | -$1.12 10-Q · filed 2019-04-29 | |||
| 2018-06-30 | -$0.07 10-Q · filed 2018-07-31 | -$0.53 10-Q · filed 2018-07-31 | ||
| 2018-03-31 | -$0.47 10-Q · filed 2019-04-29 | |||
| 2017-09-30 | -$0.13 10-Q · filed 2017-11-01 | -$1.70 10-Q · filed 2017-11-01 | ||
| 2017-06-30 | -$0.68 10-Q · filed 2018-07-31 | -$1.58 10-Q · filed 2018-07-31 | ||
| 2017-03-31 | -$0.90 10-Q · filed 2018-04-30 | |||
| 2016-12-31 | -$0.51 10-K · filed 2018-02-13 | -$1.63 10-K · filed 2018-02-13 | ||
| 2016-09-30 | -$0.43 10-K · filed 2018-02-13 | -$1.11 10-Q · filed 2017-11-01 | ||
| 2016-06-30 | -$0.46 10-K · filed 2018-02-13 | -$0.69 10-Q · filed 2017-08-03 | ||
| 2016-03-31 | -$0.22 10-K · filed 2018-02-13 | |||
| 2015-12-31 | -$0.34 10-K · filed 2017-02-14 | -$1.05 10-K · filed 2017-02-14 | ||
| 2015-09-30 | -$0.40 10-K · filed 2017-02-14 | -$0.71 10-Q · filed 2016-11-02 | ||
| 2015-06-30 | -$0.28 10-K · filed 2017-02-14 | -$0.30 10-Q · filed 2016-08-03 | ||
| 2015-03-31 | -$0.01 10-K · filed 2017-02-14 | |||
| 2014-12-31 | -$0.26 10-K · filed 2016-02-11 | -$0.81 10-K · filed 2016-02-11 | ||
| 2014-09-30 | -$0.21 10-K · filed 2016-02-11 | -$0.56 10-Q · filed 2015-10-29 | ||
| 2014-06-30 | -$0.18 10-K · filed 2016-02-11 | -$0.35 10-Q · filed 2015-07-29 | ||
| 2014-03-31 | -$0.17 10-K · filed 2016-02-11 | |||
| 2013-12-31 | -$0.16 10-K · filed 2015-02-09 | -$0.69 10-K · filed 2015-02-09 | ||
| 2013-09-30 | -$0.17 10-K · filed 2015-02-09 | -$0.53 10-Q · filed 2014-11-04 | ||
| 2013-06-30 | -$0.18 10-K · filed 2015-02-09 | -$0.36 10-Q · filed 2014-08-06 | ||
| 2013-03-31 | -$0.18 10-K · filed 2015-02-09 | |||
| 2012-09-30 | -$0.05 10-Q · filed 2013-10-29 | -$0.07 10-Q · filed 2013-10-29 | ||
| 2012-06-30 | -$0.01 10-Q · filed 2013-07-26 | -$0.02 10-Q · filed 2013-07-26 | ||
| 2012-03-31 | -$0.01 10-Q · filed 2013-05-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |